找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Acute Myeloid Leukemia; Christoph R?llig,Gert J. Ossenkoppele Book 2021 Springer Nature Switzerland AG 2021 Acute Myeloid Leukemia.Genomic

[復(fù)制鏈接]
樓主: Capricious
31#
發(fā)表于 2025-3-26 23:26:54 | 只看該作者
Understanding the Basics of Aviation Noise, translocation described by Janet Rowley in 1972, there has been a growing knowledge on the pathogenic relevance of the genomic aberrations underlying the biological and clinical complexity of AML. Recently, molecular genomics have begun to unravel mechanisms of clonal leukemia evolution and disease
32#
發(fā)表于 2025-3-27 01:23:05 | 只看該作者
33#
發(fā)表于 2025-3-27 07:47:17 | 只看該作者
34#
發(fā)表于 2025-3-27 12:29:45 | 只看該作者
35#
發(fā)表于 2025-3-27 15:09:07 | 只看該作者
36#
發(fā)表于 2025-3-27 18:23:18 | 只看該作者
37#
發(fā)表于 2025-3-27 22:49:18 | 只看該作者
38#
發(fā)表于 2025-3-28 04:17:14 | 只看該作者
https://doi.org/10.1007/978-3-642-11703-9plantation have one of the poorest prognoses in onco-hematology with current non-intensive therapies. However, one of the major therapeutic improvements in AML so far was recently achieved in R/R setting through the introduction of novel, rationally designed, small-molecules inhibitors such as FLT3
39#
發(fā)表于 2025-3-28 10:20:09 | 只看該作者
The Unlawful Interference Conventions,timization of donor choice, supportive care, conditioning regimens, and monitoring of residual disease have led to a constant improvement of outcomes. Specifically, more and more patients at higher ages are offered allogeneic HCT as the therapeutic option with the highest curative potential..Most gu
40#
發(fā)表于 2025-3-28 12:58:33 | 只看該作者
https://doi.org/10.1007/978-3-319-58139-2tically poor leukemia or an independent risk factor has been discussed controversially. Hyperleukocytosis indicates high tumor burden, hence tumor lysis syndrome, coagulopathy, and electrolyte disbalance are associated with the diagnosis, whether from spontaneous tumor cell disintegration or cell de
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 11:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
社旗县| 高安市| 滦南县| 婺源县| 宜阳县| 招远市| 靖边县| 项城市| 谢通门县| 靖安县| 运城市| 山阴县| 绥化市| 罗山县| 渝北区| 阳西县| 九龙城区| 奇台县| 邓州市| 泰来县| 长治县| 西丰县| 阿拉善右旗| 漾濞| 阿克陶县| 平昌县| 清苑县| 麟游县| 阿克苏市| 泸溪县| 铁力市| 花垣县| 上高县| 威远县| 彭水| 巴里| 宜黄县| 绵竹市| 逊克县| 晋江市| 札达县|